Science Current Events | Science News | Brightsurf.com
 
corner top left block corner top right

Obesity predisposition traced to the brain's reward system

July 30, 2008

The tendency toward obesity is directly related to the brain system that is involved in food reward and addictive behaviors, according to a new study. Researchers at Tufts University School of Medicine (TUSM) and colleagues have demonstrated a link between a predisposition to obesity and defective dopamine signaling in the mesolimbic system in rats. Their report appears in the August 2008 issue of The FASEB Journal.

The mesolimbic system is a system of neurons in the brain that secretes dopamine, a neurotransmitter or chemical messenger, which mediates emotion and pleasure. The release of the neurotransmitter dopamine in the mesolimbic system is traditionally associated with euphoria and considered to be the major neurochemical signature of drug addiction.

"Baseline dopamine levels were 50 percent lower and stimulated dopamine release was significantly attenuated in the brain reward systems of obesity-prone rats, compared with obesity-resistant rats. Defects in brain dopamine synthesis and release were evident in rats immediately after birth," said Emmanuel Pothos, PhD, assistant professor in the department of pharmacology and experimental therapeutics at TUSM and member of the neuroscience program faculty of the Sackler School of Graduate Biomedical Sciences.

"Previous research has demonstrated that food intake leads to an increase in the release of dopamine, in the circuits that mediate the pleasurable aspects of eating," Pothos explains. "Also, chronic food deprivation resulting in decreased body weight leads to decreased dopamine levels. Therefore, increased food intake may represent a compensatory attempt to restore baseline dopamine levels."

Pothos says, "These findings have important implications in our understanding of the obesity epidemic. The notion that decreased dopamine signaling leads to increased feeding is compatible with the finding from human studies that obese individuals have reduced central dopamine receptors." He speculates that an attenuated dopamine signal may interfere with satiation, leading to overeating.

Pothos and colleagues conducted their research using obesity-prone and obesity-resistant rats. Adult obesity-prone rats consumed more food and were 20% heavier than obesity-resistant rats.

The researchers measured electrically-evoked dopamine release from nerve terminals. "We also measured regulators of dopamine synthesis and release in midbrain dopamine pathways," explains Brenda Geiger, first author and graduate student in the pharmacology and experimental therapeutics department at TUSM. "Our molecular analysis suggests that the central dopamine deficits are most likely caused by reduced expression of the genes encoding two proteins, one that is involved in dopamine synthesis, and another that is a transporter responsible for packaging dopamine into vesicles from which it is later released upon stimulation."

"Obesity has so far been approached mostly as a metabolic rather than as an addictive disorder; and obesity research has primarily focused on brain systems that regulate body weight through the maintenance of energy balance. The current study challenges this approach by focusing on brain pathways implicated in pleasure and reward. These pathways could override energy balance and induce hyperphagia and obesity by altering the reward value of food, particularly palatable high-energy food, very early in life," says Pothos, who is the study's corresponding and senior author.

According to Gerald Weissmann, MD, editor-in-chief of The FASEB Journal, "Now we know why so many people stay addicted to food: it fuels the mid-brain pleasure machinery. We eat not only for nourishment, but also for pleasure. This study provides the molecular link between eating and mental health." The FASEB Journal (http://www.fasebj.org) is published by the Federation of American Societies for Experimental Biology (FASEB).

Tufts University, Health Sciences




Meet Your Happy Chemicals: Dopamine, Endorphin, Oxytocin, Serotonin

Meet Your Happy Chemicals: Dopamine, Endorphin, Oxytocin, Serotonin
by Loretta Graziano Breuning PhD (Author)


Humans have emotional ups and downs because we’ve inherited the operating system of earlier mammals. You feel good when you find new rewards because that triggers dopamine. You feel good when you get respect because it triggers serotonin. Building trust triggers oxytocin, and endorphin makes you feel good when you’re injured. The mammal brain releases happy chemicals when you do things that promote survival in the state of nature. You can get more happy chemicals from your brain when you understand the job it evolved to do. Happy chemicals were not meant to surge all the time. They evolved to reward you when you promote the survival of your genes. You define this in unique individuals ways because early experience builds the neural pathways that turn on the happy chemicals. But...

Dopamine Handbook

Dopamine Handbook
by Leslie Iversen (Author), Susan Iversen (Author), Stephen Dunnett (Author), Anders Bjorklund (Author)


The discovery of dopamine in 1957-1958 was one of the seminal events in the development of modern neuroscience, and has been extremely important for the development of modern therapies of neurological and psychiatric disorders. Dopamine has a fundamental role in almost all aspects of behavior: from motor control to mood regulation, cognition and addiction and reward, and dopamine research has been unique within the neurosciences in the way it has bridged basic science and clinical practice. Over the decades research into the role of dopamine in health and disease has been in the forefront of modern neuroscience. The Dopamine Handbook is the first single-volume publication to capture current progress and excitement in this dynamic research field.

The Craving Brain: A bold new approach to breaking free from *drug addiction *overeating *alcoholism *gambling

The Craving Brain: A bold new approach to breaking free from *drug addiction *overeating *alcoholism *gambling
by Ronald A. Ruden (Author)


Where do the roots of addictive behavior lie -- in our genes or in our environment, in our chemistry or in our character? In the Craving Brain, Dr. Ronald Ruden asserts that the roots of addiction most defintetly do not lie in our character. Rather, they lie in a complex chain reaction that originates in an ancient survival mechanism in the brain. When this system is inappropriately activated, it drives the body to crave, sometimes with addictive behavior as the end result. In clear, straightforward language, Dr. Ruden outlines his remarkable successful treatment program which he believes can cure this problem.The Craving Brain offers crucial insights into the world of addiction. This revolutionary book will bring hope to millions of people who suffer from a wide range of addictions, from...

You Never Miss the Dopamine...: (until the brain runs dry!)

You Never Miss the Dopamine...: (until the brain runs dry!)
by Bill Schmalfeldt (Author)


From the author of "No Doorway Wide Enough," "Undercover Trucker," and "Hunky Dunk," a real-life look at how one man deals with his Parkinson's disease decline by laughing at it. Told in a series of essays from his blog, Bill Schmalfeldt talks more about the non-motor symptoms of PD -- the speech difficulties, the bizarre dreams, the memory problems and the hallucinations -- in a way that makes the reader realize that while there's no cure for PD, it can't damage the human spirit (unless you let it)!

The Dopamine Receptors (The Receptors)

The Dopamine Receptors (The Receptors)
by Kim A. Neve (Editor)


As sites of action for drugs used to treat schizophrenia and Parkinson’s disease, dopamine receptors are among the most validated drug targets for neuropsychiatric disorders. Dopamine receptors are also drug targets or potential targets for other disorders such as substance abuse, depression, Tourette’s syndrome, and attention deficit hyperactivity disorder. Updated from the successful first edition, "The Dopamine Receptors" serves as a reference work on dopamine receptors while also highlighting the areas of research that are most active today. To achieve this goal, authors have written chapters that set a broad area of research in its historical context, rather than focusing on the research output of their own laboratories.

The Dopaminergic Mind in Human Evolution and History

The Dopaminergic Mind in Human Evolution and History
by Fred H. Previc (Author)


What does it mean to be human? There are many theories of the evolution of human behavior which seek to explain how our brains evolved to support our unique abilities and personalities. Most of these have focused on the role of brain size or specific genetic adaptations of the brain. In contrast, Fred Previc presents a provocative theory that high levels of dopamine, the most widely studied neurotransmitter, account for all major aspects of modern human behavior. He further emphasizes the role of epigenetic rather than genetic factors in the rise of dopamine. Previc contrasts the great achievements of the dopaminergic mind with the harmful effects of rising dopamine levels in modern societies and concludes with a critical examination of whether the dopaminergic mind that has evolved in...

Imaging Dopamine

Imaging Dopamine
by Paul Cumming (Author)


Since its discovery 50 years ago, brain dopamine has been implicated in the control of movement and cognition, and is concerned with diverse brain diseases such as Parkinson's disease, schizophrenia and drug addiction. This book is an illustrated biography of the dopamine molecule, from its synthesis in the brain to its signalling mechanisms and ultimately to its metabolic breakdown. Using colour illustrations of positron emission tomography (PET) scans, each chapter presents a specific stage in the biochemical pathway for dopamine. Writing for researchers and graduate students, Paul Cumming presents a compilation of all that has been learned about dopamine through molecular imaging, a technology which allows the measurement of formerly invisible processes in the living brain. He reviews...

Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance, Volume 172 (Progress in Brain Research)

Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance, Volume 172 (Progress in Brain Research)
by Giuseppe Di Giovanni (Editor), Vincenzo Di Matteo (Editor), Ennio Esposito (Editor)


This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the serotonin (5-HT)-dopamine (DA) interactions. Central serotonergic and dopaminergic systems play a critical role in the regulation of normal and abnormal behaviors. Moreover, recent evidence suggests that the dysfunction of the DA and 5-HT neurotransmitter systems contribute to various mental disorders including depression, schizophrenia, drug addiction and Parkinson's disease. This extremely important topic is of wide interest within the scientific community, with relevance not only to specialists but also to general practitioners and students. The book provides a valuable contribution to the debate on new pharmacological...

Dumb Bells & Dopamine: A Parkinson's Success Story

Dumb Bells & Dopamine: A Parkinson's Success Story
by Arthur Curren (Author)


This book is about living with Parkinson's, an incurable, debilitating disease caused by the loss of dopamine-producing cells in the brain of the afflicted person. Levodopa is the only drug that replaces some of the dopamine and exercise is the only activity that induces the brain to produce dopamine. The author uses a rigorous exercise program to reduce the dosage of levodopa and extend the useful life of this essential drug. This is the author's dumb bells and dopamine approach to controlling Parkinson's.The author has also addressed some of the social issues related to the disease. This includes dealing with less than perfect physicians and with the negative situations that exist in the insurance industry and Social Security Administration.To provide real assistance to people with the...

Overcoming qEEG Abnormalities and Reward Gene Deficits During Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine ... Therapy: Part 2 (Postgraduate Medicine)

Overcoming qEEG Abnormalities and Reward Gene Deficits During Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine ... Therapy: Part 2 (Postgraduate Medicine)
by JTE Multimedia


Background It is well established that in both food- and drug-addicted individuals there is “dopamine resistance” associated with the DRD2 gene A1 allele. Based on earlier studies, evidence is emerging wherein the potential of utilizing a natural, nonaddicting, safe, putative D2 agonist may play a significant role in the recovery of individuals with reward deficiency syndrome, including those addicted to psychoactive chemicals. Findings Positive outcomes demonstrated by quantitative electroencephalographic (qEEG) imaging in a randomized, triple-blind, placebo-controlled, crossover study involving oral Synaptose Complex KB220Z™ showed an increase of alpha waves and low beta wave activity in the parietal brain region. Using t statistics, significant differences observed between...

corner bottom left corner bottom right
© 2012 BrightSurf.com